A share price of Astrazeneca plc ADR [AZN] is currently trading at $75.40, up 0.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AZN shares have gain 0.80% over the last week, with a monthly amount glided 9.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on February 13, 2025, when UBS upgraded its rating to a Buy. On November 20, 2024, upgrade upgraded it’s rating to Neutral. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to a Sell. Goldman started tracking with a Buy rating for this stock on May 30, 2024, and assigned it a price target of $97. In a note dated April 16, 2024, Deutsche Bank upgraded an Hold rating on this stock.
Astrazeneca plc ADR experienced fluctuations in its stock price throughout the past year between $62.75 and $87.68. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $75.40 at the most recent close of the market. An investor can expect a potential return of 16.71% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Trailing Twelve Months sales for Astrazeneca plc ADR [NASDAQ:AZN] were 54.07B which represents 23.84% growth. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.18 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.91 points at the first support level, and at 74.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 76.05, and for the 2nd resistance point, it is at 76.69.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Astrazeneca plc ADR [NASDAQ:AZN] is 0.93. In addition, the Quick Ratio stands at 0.74 and the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 4.32, the price to book ratio is 5.73 and price to earnings (TTM) ratio is 33.46.
